DiMichele, Donna

selected publications

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study. Haemophilia : the official journal of the World Federation of Hemophilia. 2015 Academic Article GET IT
Times cited: 17
Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia : the official journal of the World Federation of Hemophilia. 2013 Academic Article GET IT
Times cited: 8
Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database. Haemophilia : the official journal of the World Federation of Hemophilia. 2012 Academic Article GET IT
Times cited: 17
The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Blood. 2012 Academic Article GET IT
Times cited: 91
Paroxysmal nocturnal hemoglobinuria in pediatric patients. Pediatric blood & cancer. 2011 Academic Article GET IT
Times cited: 30
The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood. 2011 Academic Article GET IT
Times cited: 294
Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2011 Academic Article GET IT
Times cited: 6
Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia. 2011 Academic Article GET IT
Times cited: 9
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia. Gene therapy. 2011 Academic Article GET IT
Times cited: 115
Neoangiogenesis contributes to the development of hemophilic synovitis. Blood. 2010 Academic Article GET IT
Times cited: 104
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). Haemophilia : the official journal of the World Federation of Hemophilia. 2010 Academic Article GET IT
Times cited: 11
The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemporary clinical trials. 2009 Academic Article GET IT
Times cited: 20
Pharmacokinetics and safety of fibrinogen concentrate. Journal of thrombosis and haemostasis : JTH. 2009 Academic Article GET IT
Times cited: 85
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 96
Risk factors for inhibitor formation in haemophilia: a prevalent case-control study. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 62
Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia. 2009 Academic Article GET IT
Times cited: 23
Power Doppler sonography in the diagnosis of hemophilic synovitis--a promising tool. Journal of thrombosis and haemostasis : JTH. 2008 Academic Article GET IT
Times cited: 50
Haemophilia in the first years of life. Haemophilia : the official journal of the World Federation of Hemophilia. 2008 Academic Article GET IT
Times cited: 26
A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. Pediatric blood & cancer. 2008 Academic Article GET IT
Times cited: 17
Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia. 2007 Academic Article GET IT
Times cited: 47
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 1316
Inhibitor development in haemophilia B: an orphan disease in need of attention. British journal of haematology. 2007 Information Resource GET IT
Times cited: 175
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach. Journal of thrombosis and haemostasis : JTH. 2007 Information Resource GET IT
Times cited: 35
Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Information Resource GET IT
Times cited: 24
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2006 Academic Article GET IT
Times cited: 331
The international immune tolerance study: a multicenter prospective randomized trial in progress. Journal of thrombosis and haemostasis : JTH. 2006 Article GET IT
Times cited: 55
A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia : the official journal of the World Federation of Hemophilia. 2006 Academic Article GET IT
Times cited: 99
Management of factor VIII inhibitors. International journal of hematology. 2006 Information Resource GET IT
Times cited: 25
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia. 2004 Academic Article GET IT
Times cited: 132
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of thrombosis and haemostasis : JTH. 2004 Academic Article GET IT
Times cited: 213
Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia : the official journal of the World Federation of Hemophilia. 2003 Academic Article GET IT
Times cited: 31
Gene therapy ethics and haemophilia: an inevitable therapeutic future?. Haemophilia : the official journal of the World Federation of Hemophilia. 2003 Information Resource GET IT
Times cited: 19
Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa. 2001 GET IT
Times cited: 34

VIVO Weill Cornell Medical College

Donna DiMichele Clinical Professor of Pediatrics

Publications

selected publications

Contact

full name

primary email